| Symbol |
Name |
|
AATK
|
apoptosis-associated tyrosine kinase
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
AKAP9
|
A kinase (PRKA) anchor protein 9
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
CACNA1B
|
calcium channel, voltage-dependent, N type, alpha 1B subunit
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
DNM1L
|
dynamin 1-like
|
|
ENSA
|
endosulfine alpha
|
|
ESR1
|
estrogen receptor 1
|
|
FMR1
|
fragile X mental retardation 1
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABBR2
|
gamma-aminobutyric acid (GABA) B receptor, 2
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HNRNPL
|
heterogeneous nuclear ribonucleoprotein L
|
|
JUN
|
jun proto-oncogene
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KCNA4
|
potassium channel, voltage gated shaker related subfamily A, member 4
|
|
KCNAB2
|
potassium channel, voltage gated subfamily A regulatory beta subunit 2
|
|
KCNB1
|
potassium channel, voltage gated Shab related subfamily B, member 1
|
|
KCNC1
|
potassium channel, voltage gated Shaw related subfamily C, member 1
|
|
KCNC3
|
potassium channel, voltage gated Shaw related subfamily C, member 3
|
|
KCNC4
|
potassium channel, voltage gated Shaw related subfamily C, member 4
|
|
KCND2
|
potassium channel, voltage gated Shal related subfamily D, member 2
|
|
KCNE1
|
potassium channel, voltage gated subfamily E regulatory beta subunit 1
|
|
KCNE3
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ12
|
potassium channel, inwardly rectifying subfamily J, member 12
|
|
KCNJ13
|
potassium channel, inwardly rectifying subfamily J, member 13
|
|
KCNJ3
|
potassium channel, inwardly rectifying subfamily J, member 3
|
|
KCNJ4
|
potassium channel, inwardly rectifying subfamily J, member 4
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
|
KCNK2
|
potassium channel, two pore domain subfamily K, member 2
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNK9
|
potassium channel, two pore domain subfamily K, member 9
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KCNMB4
|
potassium channel subfamily M regulatory beta subunit 4
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
|
KCNN4
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KCNQ3
|
potassium channel, voltage gated KQT-like subfamily Q, member 3
|
|
KCNT1
|
potassium channel, sodium activated subfamily T, member 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MINK1
|
misshapen-like kinase 1
|
|
MSN
|
moesin
|
|
NACC1
|
nucleus accumbens associated 1, BEN and BTB (POZ) domain containing
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RGS10
|
regulator of G-protein signaling 10
|
|
RGS7
|
regulator of G-protein signaling 7
|
|
RPH3A
|
rabphilin 3A
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TH
|
tyrosine hydroxylase
|
|
TP53
|
tumor protein p53
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
